From: Methylation mediated silencing of TMS1/ASC gene in prostate cancer
 | Prostate cancer | Control (BPH) |  | ||
---|---|---|---|---|---|
 | n | % | n | % | P-value |
Race | Â | Â | Â | Â | Â |
   Black | 21 | 31.8 | 12 | 35.3 | 0.82 |
   White | 45 | 68.2 | 22 | 64.7 |  |
Stage | Â | Â | Â | Â | Â |
   II | 42 | 63.6 |  |  |  |
   III | 19 | 28.8 |  |  |  |
   IV | 4 | 6.1 |  |  |  |
   Unknown | 1 | 1.5 |  |  |  |
Gleason Score | Â | Â | Â | Â | Â |
   5 | 3 | 4.6 |  |  |  |
   6 | 26 | 39.4 |  |  |  |
   7 | 32 | 48.4 |  |  |  |
   8 | 3 | 4.6 |  |  |  |
   9 | 2 | 3.0 |  |  |  |
Preoperative serum PSA | Â | Â | Â | Â | Â |
   < 4 | 5 | 7.6 |  |  |  |
   4.0 – 8 | 46 | 69.7 |  |  |  |
   8.1 – 12 | 8 | 12.1 |  |  |  |
   > 12 | 7 | 10.6 |  |  |  |
Mean age (range) | 64 yrs (51 – 80) | 71 yrs (53 – 88) | < 0.001 |